nexopamil has been researched along with ketanserin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirchengast, M; Lehmann, HD; Rübsamen, K | 1 |
| Boulanger, CM; Kirchengast, M; Park, SJ; Vanhoutte, PM | 1 |
| López-Novoa, JM; Montero, A; Reverte, M; Rodríguez-López, A | 1 |
3 other study(ies) available for nexopamil and ketanserin
| Article | Year |
|---|---|
Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Topics: Animals; Calcium; Coronary Circulation; Coronary Thrombosis; Dogs; Female; Gallopamil; Hemodynamics; Injections, Intravenous; Ketanserin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1993 |
Effects of the combined 5-hydroxytryptamine2 receptor and Ca2+ channel antagonist LU49938 on the responsiveness of isolated porcine coronary arteries with and without endothelium.
Topics: Analysis of Variance; Animals; Calcium-Binding Proteins; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Serotonin; Serotonin Antagonists; Swine; Verapamil | 1994 |
The effect of LU-49938 (nexopamil) on the activation by serotonin of mesangial cells.
Topics: Animals; Cell Count; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Glomerular Mesangium; Ketanserin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Thymidine; Time Factors; Verapamil | 1995 |